Conference abstract · 7 Nov 2016
Conference abstractPublished 27 Oct 2014
Challenges for biosimilar generics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilars are recombinantly produced drugs and are similar to reference biologic. Although, defined, specific and well planned guidelines for Biosimilars are available world-wide, yet the biosimilar drugs face lot of challenge from the patenting strategies from their innovator competitors. Interestingly, most of the innovators not only protect their Biopharmaceuticals in form of product patents but also in form of formulations, delivery systems, preparing methods and their use. However, the biosimilar generics face even a greater challenge from innovator?s devising strategies for developing better and enhanced efficacious Biopharmaceuticals than the existing ones, as the new and improved versions of Biopharmaceuticals can be of concern for biosimilar generics. Therefore it is pertinent for biosimilar generics to understand the patenting strategies of the innovators for Biopharmaceuticals they have developed. In addition, the biosimilar generics need also undertake a comprehensive review of the prosecution strategies of the innovators, which can provide them a good insight to prevent any legal issues.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Sep 2014
Why aren’t biosimilars generics - regulatory challenges
Article · 17 Jun 2024
Generic and Biosimilar Drug Interchangeability and Innovations
Editorial · 28 Jan 2022
International Conference on Biosimilars and Generic Drugs
Commentary · 27 Oct 2021
Critical Differences in Generics and Biosimilars
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Vivek Kashyap”

